Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Urol. 2017 May 18;198(4):848–857. doi: 10.1016/j.juro.2017.05.065

Table 2b.

Ordinal Logistic Regression - Urinary Severity (Adjusted for Baseline Severity)

Obs Used Variable Estimate P-value OR (99% CI) C statistic
397 Age −0.005 0.451 0.995 (0.977–1.013) 0.679
397 Sex (0=Males, 1=Females) −0.294 0.172 0.745 (0.428–1.298) 0.679
397 Race: White 0.292 0.374 1.339 (0.575–3.119) 0.680
397 Non-Hispanic −0.028 0.951 0.972 (0.299–3.163) 0.677
362 Income 0.011 0.899 1.011 (0.809–1.264) 0.676
389 Duration of symptom(yrs) −0.017 0.098 0.983 (0.958–1.009) 0.682
397 Duration of symptom: 0:<2yr,1:>=2yrs −0.506 0.020 0.603 (0.345–1.055) 0.688
397 Pain Severity at Baseline −0.010 0.646 0.990 (0.935–1.048) 0.677
396 CMSI Non-Uro symptoms −0.054 0.001 0.947 (0.907–0.990) 0.694
397 Body Map Sites Non-pelvic (0–42) −0.055 0.002 0.946 (0.903–0.991) 0.693
397 Body Map: Head (y/n) −0.448 0.039 0.639 (0.366–1.116) 0.681
377 PCS (0–100) 0.033 0.005 1.033 (1.003–1.065) 0.695
377 MCS (0–100) −0.007 0.499 0.993 (0.966–1.020) 0.677
396 Fatigue Score (29.4 – 83.2) −0.035 0.008 0.966 (0.934–0.999) 0.688
396 Sleep disturbance(28.9 – 76.5) −0.035 0.006 0.965 (0.934–0.998) 0.694
396 Anger (32.4 – 85.2) −0.003 0.803 0.997 (0.966–1.029) 0.677
395 HADS: Depression (0–21) 0.003 0.902 1.003 (0.937–1.074) 0.678
395 HADS: Anxiety (0–21) −0.005 0.832 0.995 (0.936–1.058) 0.677
395 CSQ: CAT total score (0–36) −0.011 0.394 0.989 (0.958–1.022) 0.677
394 PSS total (0–40) −0.011 0.446 0.989 (0.955–1.025) 0.677
359 SEAR Total Score (0–100) −0.001 0.910 0.999 (0.982–1.017) 0.677
384 % of Visits with Medication Change −0.012 0.054 0.988 (0.972–1.004) 0.681

Negative estimates indicate lower likelihood of improvement with higher value of predictor variable.

Bold values indicate significant (p<.01) estimates.